• 676 Citations
  • 14 h-Index
19992019
If you made any changes in Pure these will be visible here soon.

Personal profile

External positions

SA Health

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2019

1 Citation (Scopus)

Azacitidine with or without lenalidomide in higher risk myelodysplastic syndrome & low blast acute myeloid leukemia

Kenealy, M., Hertzberg, M., Benson, W., Taylor, K., Cunningham, I., Stevenson, W., Hiwase, D., Eek, R., Zantomio, D., Jong, S., Wall, M., Blombery, P., Gerber, T., Debrincat, M., Zannino, D. & Seymour, J. F., 31 Mar 2019, In : Haematologica. 104, 4, p. 700-709 10 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Comprehensive geriatric assessment predicts azacitidine treatment duration and survival in older patients with myelodysplastic syndromes

Molga, A., Wall, M., Chhetri, R., Wee, L. Y., Singhal, D., Edwards, S., Singhal, N., Ross, D., To, L. B., Caughey, G., Shakib, S., Germing, U., To, T. & Hiwase, D., 1 Jan 2019, In : Journal of Geriatric Oncology.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Modeling the safe minimum frequency of molecular monitoring for CML patients attempting treatment-free remission

Shanmuganathan, N., Braley, J. A., Yong, A., Hiwase, D., Yeung, D., Ross, D., Hughes, T. & Branford, S., 4 Jul 2019, In : Blood. 134, 1, p. 85-89 5 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

Red cell autoimmunization and alloimmunization in myelodysplastic syndromes: Prevalence, characteristic and significance

Chhetri, R., Wee, L. Y., Sinha, R., Kutyna, M. M., Pham, A., Stathopoulos, H., Nath, L., Nath, S. V., Wickham, N., Hughes, T., Singhal, D., Roxby, D. J. & Hiwase, D., 1 Jan 2019, In : Haematologica. 104, 10, p. E451-E454

Research output: Contribution to journalLetter